Showing results (111-120 of 147) with videos related to

Sort By:
Pageof 15
JACC. Clinical Electrophysiology|May 16, 2018
Multicenter Outcomes for Catheter Ablation of Idiopathic Premature Ventricular ComplexesRakesh Latchamsetty, Miki Yokokawa, Fred Morady, et al.
Circulation. Arrhythmia and Electrophysiology|August 21, 2013
Sinoatrial node reentry in a canine chronic left ventricular infarct model: role of intranodal fibrosis and heterogeneity of refractorinessAlexey V Glukhov, Lori T Hage, Brian J Hansen, et al.
Journal of Cardiovascular Electrophysiology|June 6, 2022
Process mapping strategies to prevent subcutaneous implantable cardioverter-defibrillator infectionsRaul Weiss, George E Mark, Mikhael F El-Chami, et al.
Pacing and Clinical Electrophysiology : PACE|April 9, 2020
Diagnosis and management of subcutaneous implantable cardioverter-defibrillator infections based on process mappingLarry M Baddour, Raul Weiss, George E Mark, et al.
Circulation|August 28, 2013
Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillatorRaul Weiss, Bradley P Knight, Michael R Gold, et al.
Journal of Cardiovascular Electrophysiology|January 23, 2022
Device-related infection associated with increased mortality risk in de novo transvenous implantable cardioverter-defibrillator medicare patientsMikhael F El-Chami, Yiyan Liu, Robert I Griffiths, et al.
Heart Rhythm|August 9, 2022
Infection in patients with subcutaneous implantable cardioverter-defibrillator: Results of the S-ICD Post Approval StudyMichael R Gold, Johan D Aasbo, Raul Weiss, et al.
Heart Rhythm|February 11, 2018
Techniques for successful early retrieval of the Micra transcatheter pacing system: A worldwide experienceMuhammad R Afzal, Emile G Daoud, Ryan Cunnane, et al.
Life Sciences|November 22, 2019
Chronic heart failure increases negative chronotropic effects of adenosine in canine sinoatrial cells via A1R stimulation and GIRK-mediated IKadoVictor P Long, Ingrid M Bonilla, Stephen Baine, et al.
Heart Rhythm|November 29, 2016
Performance of the subcutaneous implantable cardioverter-defibrillator in patients with a primary prevention indication with and without a reduced ejection fraction versus patients with a secondary prevention indicationLucas V Boersma, Craig S Barr, Martin C Burke, et al.
Pageof 15